vs
Side-by-side financial comparison of biote Corp. (BTMD) and CASS INFORMATION SYSTEMS INC (CASS). Click either name above to swap in a different company.
biote Corp. is the larger business by last-quarter revenue ($46.4M vs $26.2M, roughly 1.8× CASS INFORMATION SYSTEMS INC). CASS INFORMATION SYSTEMS INC runs the higher net margin — 31.3% vs 4.2%, a 27.1% gap on every dollar of revenue. On growth, CASS INFORMATION SYSTEMS INC posted the faster year-over-year revenue change (-1.3% vs -6.9%). biote Corp. produced more free cash flow last quarter ($6.5M vs $4.1M). Over the past eight quarters, biote Corp.'s revenue compounded faster (-0.4% CAGR vs -2.8%).
biote Corp is a healthcare company specializing in personalized bioidentical hormone replacement therapy solutions for adult men and women. It operates primarily in the U.S. market, offering training programs for licensed healthcare providers, along with complementary wellness supplements and diagnostic services to support patient care outcomes.
Cass Information Systems Inc is a leading provider of integrated financial automation and information management solutions for enterprises. Its core services cover freight payment processing, utility expense management, commercial payment services, and supporting data analytics tools, helping clients streamline financial workflows, cut operational costs, and gain clearer cross-category spending visibility to support smarter business decisions.
BTMD vs CASS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $46.4M | $26.2M |
| Net Profit | $2.0M | $8.2M |
| Gross Margin | — | — |
| Operating Margin | 14.7% | 38.1% |
| Net Margin | 4.2% | 31.3% |
| Revenue YoY | -6.9% | -1.3% |
| Net Profit YoY | -47.2% | 78.3% |
| EPS (diluted) | $0.05 | $0.61 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $46.4M | $26.2M | ||
| Q3 25 | $48.0M | $27.4M | ||
| Q2 25 | $48.9M | $27.6M | ||
| Q1 25 | $49.0M | $26.8M | ||
| Q4 24 | $49.8M | $26.5M | ||
| Q3 24 | $51.4M | $28.1M | ||
| Q2 24 | $49.2M | $27.6M | ||
| Q1 24 | $46.8M | $27.7M |
| Q4 25 | $2.0M | $8.2M | ||
| Q3 25 | $8.2M | $9.1M | ||
| Q2 25 | $3.2M | $8.9M | ||
| Q1 25 | $13.7M | $9.0M | ||
| Q4 24 | $3.7M | $4.6M | ||
| Q3 24 | $10.7M | $2.9M | ||
| Q2 24 | $-7.1M | $4.5M | ||
| Q1 24 | $-4.2M | $7.2M |
| Q4 25 | 14.7% | 38.1% | ||
| Q3 25 | 17.2% | 42.3% | ||
| Q2 25 | 22.0% | 22.8% | ||
| Q1 25 | 19.8% | 40.6% | ||
| Q4 24 | 5.6% | 19.7% | ||
| Q3 24 | 23.7% | 13.4% | ||
| Q2 24 | 12.7% | 20.2% | ||
| Q1 24 | 22.3% | 32.1% |
| Q4 25 | 4.2% | 31.3% | ||
| Q3 25 | 17.1% | 33.2% | ||
| Q2 25 | 6.5% | 32.1% | ||
| Q1 25 | 28.0% | 33.5% | ||
| Q4 24 | 7.4% | 17.3% | ||
| Q3 24 | 20.8% | 10.5% | ||
| Q2 24 | -14.4% | 16.2% | ||
| Q1 24 | -8.9% | 25.8% |
| Q4 25 | $0.05 | $0.61 | ||
| Q3 25 | $0.22 | $0.68 | ||
| Q2 25 | $0.10 | $0.66 | ||
| Q1 25 | $0.37 | $0.66 | ||
| Q4 24 | $0.09 | $0.34 | ||
| Q3 24 | $0.33 | $0.21 | ||
| Q2 24 | $-0.21 | $0.32 | ||
| Q1 24 | $-0.12 | $0.52 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $24.1M | $758.4M |
| Total DebtLower is stronger | $103.1M | — |
| Stockholders' EquityBook value | $-58.5M | $243.0M |
| Total Assets | $107.6M | $2.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $24.1M | $758.4M | ||
| Q3 25 | $28.0M | $486.6M | ||
| Q2 25 | $19.6M | $431.2M | ||
| Q1 25 | $41.7M | $428.9M | ||
| Q4 24 | $39.3M | $680.1M | ||
| Q3 24 | $38.2M | $432.0M | ||
| Q2 24 | $26.4M | $441.7M | ||
| Q1 24 | $78.8M | $368.3M |
| Q4 25 | $103.1M | — | ||
| Q3 25 | $104.7M | — | ||
| Q2 25 | $106.3M | — | ||
| Q1 25 | $107.8M | — | ||
| Q4 24 | $109.4M | — | ||
| Q3 24 | $110.9M | — | ||
| Q2 24 | $112.5M | — | ||
| Q1 24 | $114.1M | — |
| Q4 25 | $-58.5M | $243.0M | ||
| Q3 25 | $-72.8M | $243.4M | ||
| Q2 25 | $-85.1M | $240.8M | ||
| Q1 25 | $-90.0M | $234.2M | ||
| Q4 24 | $-105.9M | $229.0M | ||
| Q3 24 | $-130.3M | $237.6M | ||
| Q2 24 | $-143.2M | $229.9M | ||
| Q1 24 | $-36.0M | $229.5M |
| Q4 25 | $107.6M | $2.6B | ||
| Q3 25 | $111.3M | $2.5B | ||
| Q2 25 | $104.8M | $2.3B | ||
| Q1 25 | $123.4M | $2.3B | ||
| Q4 24 | $122.4M | $2.4B | ||
| Q3 24 | $101.3M | $2.3B | ||
| Q2 24 | $92.9M | $2.3B | ||
| Q1 24 | $160.1M | $2.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $7.6M | $4.8M |
| Free Cash FlowOCF − Capex | $6.5M | $4.1M |
| FCF MarginFCF / Revenue | 14.0% | 15.8% |
| Capex IntensityCapex / Revenue | 2.3% | 2.7% |
| Cash ConversionOCF / Net Profit | 3.87× | 0.59× |
| TTM Free Cash FlowTrailing 4 quarters | $30.2M | $31.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.6M | $4.8M | ||
| Q3 25 | $14.1M | $12.3M | ||
| Q2 25 | $7.1M | $-1.3M | ||
| Q1 25 | $6.5M | $21.6M | ||
| Q4 24 | $12.4M | $18.6M | ||
| Q3 24 | $15.6M | $-198.0K | ||
| Q2 24 | $9.9M | $10.7M | ||
| Q1 24 | $7.4M | $9.8M |
| Q4 25 | $6.5M | $4.1M | ||
| Q3 25 | $13.6M | $11.3M | ||
| Q2 25 | $5.3M | $-2.6M | ||
| Q1 25 | $4.8M | $19.0M | ||
| Q4 24 | $10.7M | $18.4M | ||
| Q3 24 | $14.0M | $-2.2M | ||
| Q2 24 | $7.4M | $7.9M | ||
| Q1 24 | $6.7M | $6.3M |
| Q4 25 | 14.0% | 15.8% | ||
| Q3 25 | 28.3% | 41.1% | ||
| Q2 25 | 10.8% | -9.5% | ||
| Q1 25 | 9.9% | 71.0% | ||
| Q4 24 | 21.5% | 69.5% | ||
| Q3 24 | 27.3% | -8.0% | ||
| Q2 24 | 15.1% | 28.6% | ||
| Q1 24 | 14.2% | 22.9% |
| Q4 25 | 2.3% | 2.7% | ||
| Q3 25 | 1.0% | 3.8% | ||
| Q2 25 | 3.7% | 4.9% | ||
| Q1 25 | 3.3% | 9.6% | ||
| Q4 24 | 3.4% | 0.7% | ||
| Q3 24 | 3.0% | 7.2% | ||
| Q2 24 | 5.1% | 10.1% | ||
| Q1 24 | 1.5% | 12.6% |
| Q4 25 | 3.87× | 0.59× | ||
| Q3 25 | 1.72× | 1.35× | ||
| Q2 25 | 2.22× | -0.15× | ||
| Q1 25 | 0.47× | 2.41× | ||
| Q4 24 | 3.34× | 4.06× | ||
| Q3 24 | 1.45× | -0.07× | ||
| Q2 24 | — | 2.38× | ||
| Q1 24 | — | 1.37× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BTMD
| Product Revenue | $45.3M | 98% |
| Disposable Trocars Product Revenue | $1.2M | 3% |
CASS
| Processing Fees | $15.9M | 61% |
| Financial Fees | $9.9M | 38% |
